Q1 2025 Adapthealth Corp Earnings Call Transcript
Key Points
- First quarter revenue exceeded the midpoint of guidance by $13.1 million, driven by strong performance in the Respiratory Health and Diabetes Health segments.
- The Diabetes Health segment showed signs of recovery with sequential improvement in new starts and the best resupply attrition rate in two years.
- AdaptHealth Corp (AHCO) reduced its debt balance by $25 million in Q1, contributing to a total debt repayment of $195 million over the last five quarters.
- The company is on track to achieve its free cash flow guidance for the full year, with a significant improvement from negative $38.9 million in the prior year quarter to negative $0.1 million.
- AdaptHealth Corp (AHCO) has a broad geographic footprint with over 660 locations, positioning it well to capture market share and lead the transformation of the home health industry.
- First quarter adjusted EBITDA declined 19.3% from the prior year quarter, and the adjusted EBITDA margin decreased from 20.0% to 16.4%.
- Net revenue for the first quarter declined 1.8% compared to the prior year quarter, partly due to one less business day.
- The Sleep Health segment underperformed expectations, with net revenue decreasing 2.8% and new setups slightly behind expectations.
- Free cash flow was negative, and certain cash collections anticipated in the first quarter were pushed into the second quarter.
- The company reduced its full-year revenue expectations by $40 million and adjusted EBITDA expectations by $5 million due to the disposition of certain incontinence assets.
Good day, everyone, and welcome to today's AdaptHealth first-quarter 2025 earnings release. Today's speakers will be Suzanne Foster, Chief Executive Officer of AdaptHealth; and Jason Clemens, Chief Financial Officer of AdaptHealth. Before we begin, I would like to remind everyone that statements included in this conference call and in the press release issued today may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act. These statements include, but are not limited to, comments regarding financial results for 2025 and beyond. Actual results could differ materially from those projected in forward-looking statements because of a number of risk factors and uncertainties, which are discussed at length in the company's annual and quarterly SEC filings.
AdaptHealth Corp. has no obligation to update the information provided on this call to reflect such subsequent events. Additionally, on this morning's call, the company will reference certain financial measures such as EBITDA, adjusted EBITDA, and adjusted EBITDA margin, and free cash flow, all of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
